Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4

被引:162
作者
Joosten, Simone A.
van Meijgaarden, Krista E.
Savage, Nigel D. L.
de Boert, Tjitske
Triebel, Frederic
van der Wal, Annemieke
de Heer, Emile
Klein, Michel R.
Geluk, Annemieke
Ottenhoff, Tom H. M.
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands
[4] Immutep SA, Fac Pharm, F-92296 Chatenay Malabry, France
关键词
infectious diseases;
D O I
10.1073/pnas.0702257104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Regulatory T cells (Treg) comprise multiple subsets and are important in controlling immunity and inflammation. However, the induction and mode of action of the various distinct Treg subsets remain ill defined, particularly in humans. Here, we describe a human CD8(+)lymphocyte activation gene-3 (LAG-3)(+)CD25(+)FoxP3(+) Treg subset, which suppresses T cells partly through the secretion of CC chemokine ligand 4 (CCL4), which can inhibit T cell activation by interfering with T cell receptor signaling. CD8(+) Tregs are expanded by antigen in in vivo-primed donors, and can be detected in pathogeri infected human tissue. This CD8(+)LAG-3(+)CD25(+)FoxP3(+)CCL4(+) Treg subset thus may play a role in immunoregulation in humans, including infectious diseases.
引用
收藏
页码:8029 / 8034
页数:6
相关论文
共 37 条
[1]  
Algood HMS, 2004, J IMMUNOL, V173, P3287
[2]   The success and failure of BCG - implications for a novel tuberculosis vaccine [J].
Andersen, P ;
Doherty, TM .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (08) :656-662
[3]   Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis:: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine [J].
Andres, PG ;
Beck, PL ;
Mizoguchi, E ;
Mizoguchi, A ;
Bhan, AK ;
Dawson, T ;
Kuziel, WA ;
Maeda, N ;
MacDermott, RP ;
Podolsky, DK ;
Reinecker, HC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6303-6312
[4]   Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis [J].
Badewa, AP ;
Quinton, LJ ;
Shellito, JE ;
Mason, CM .
TUBERCULOSIS, 2005, 85 (03) :185-195
[5]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[6]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[7]  
BLOOM BR, 1992, ANNU REV IMMUNOL, V10, P453, DOI 10.1146/annurev.iy.10.040192.002321
[8]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[9]   IL-10-producing T cells suppress immune responses in anergic tuberculosis patients [J].
Boussiotis, VA ;
Tsai, EY ;
Yunis, EJ ;
Thim, S ;
Delgado, JC ;
Dascher, CC ;
Berezovskaya, A ;
Rousset, D ;
Reynes, JM ;
Goldfeld, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1317-1324
[10]   Neuropilin-1: a surface marker of regulatory T cells [J].
Bruder, D ;
Probst-Kepper, M ;
Westendorf, AM ;
Geffers, R ;
Beissert, S ;
Loser, K ;
von Boehmer, H ;
Buer, J ;
Hansen, W .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :623-630